| Differential control of proto-oncogene c-myc and c-fos expression in lymphocytes and fibroblasts. | None |
| Regulation of c-myc and c-fos proto-oncogene expression by animal cell growth factors. | None |
| Oncogenic MYC induces the impaired ribosome biogenesis checkpoint.MYC regulates the expression of RPL5 and RPL11 at the mRNA level.TP53 stability is regulated by MYC. | None |
| Immortalization of mouse neural precursor cells by the c-myc oncogene. | None |
| Coronary flow as a determinant of c-myc and c-fos proto-oncogene expression in an isolated adult rat heart. | None |
| MYMLR was identified to maintain MYC transcriptional activity and cell cycle progression despite low levels of expression. A proteomic search for MYMLR-binding proteins identified PCBP2, while it was also found that MYMLR places a 557-kb upstream enhancer region in the proximity of the MYC promoter in cooperation with PCBP2. These findings implicate a crucial role for MYMLR in regulation MYC oncogene. | None |
| The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth. | None |
| Data suggest that the mechanism of action of Omomyc is to bind DNA as either a homodimer or a heterodimer with Max that is formed cotranslationally, revealing a novel mechanism to inhibit the MYC oncogene. | None |
| Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry. | None |
| Knockdown of ANGPTL4 rescued the tumor suppressive phenotype of LMX1A overexpression, which indicated that LMX1A upregulates ANGPTL4 to exert its role. Mechanistically, we found that LMX1A inhibited the expression of the oncogene C-Myc, which is alleviated by ANGPTL4 knockdown. | None |
| SUMOylation down-regulates rDNA transcription by repressing expression of upstream-binding factor and proto-oncogene c-Myc | None |
| Multifactorial regulation of the human c-myc oncogene. | None |
| Tumorigenic transformation of rat FR3T3 fibroblasts carrying an activated myc oncogene requires subsequent mutational events. | None |
| The effect of a transfected c-myc proto-oncogene on cellular differentiation. | None |
| Nucleotide sequence 3 to the human c-myc oncogene; presence of a long inverted repeat. | None |
| Steroid-induced cell proliferation in vivo is associated with increased c-myc proto-oncogene transcript abundance. | None |
| Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. | None |
| N-myc proto-oncogene expression can induce DNA replication in Balb/c 3T3 fibroblasts. | None |
| Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts. | None |
| Alteration of morphogenesis by the v-myc oncogene in transplants of mammary gland. | None |